Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Neutrophil Count and the Inflammation-based Glasgow Prognostic Score Predict Survival in Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy

  • Li, Qing-Qing (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Lu, Zhi-Hao (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Yang, Li (Department of Oncology, Zhangzhou Municipal Hospital) ;
  • Lu, Ming (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Zhang, Xiao-Tian (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Li, Jian (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Zhou, Jun (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Wang, Xi-Cheng (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Gong, Ji-Fang (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Gao, Jing (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Li, Jie (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Li, Yan (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute) ;
  • Shen, Lin (Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute)
  • Published : 2014.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To explore the value of systemic inflammatory markers as independent prognostic factors and the extent these markers improve prognostic classification for patients with inoperable advanced or metastatic gastric cancer (GC) receiving palliative chemotherapy. Methods: We studied the prognostic value of systemic inflammatory factors such as circulating white blood cell count and its components as well as that combined to form inflammation-based prognostic scores (Glasgow Prognostic Score (GPS), Neutrophil-Lymphocyte Ratio (NLR), Platelet Lymphocyte Ratio (PLR), Prognostic Index (PI) and Prognostic Nutritional Index (PNI)) in 384 patients with inoperable advanced or metastatic gastric cancer (GC) receiving first-line chemotherapy. Univariate and multivariate analyses were performed to examine the impact of inflammatory markers on overall survival (OS). Results: Univariate analysis revealed that an elevated white blood cell, neutrophil and/or platelet count, a decreased lymphocyte count, a low serum albumin concentration, and high CRP concentration, as well as elevated NLR/PLR, GPS, PI, PNI were significant predictors of shorter OS. Multivariate analysis demonstrated that only elevated neutrophil count (HR 3.696, p=0.003) and higher GPS (HR 1.621, p=0.01) were independent predictors of poor OS. Conclusion: This study demonstrated elevated pretreatment neutrophil count and high GPS to be independent predictors of shorter OS in inoperable advanced or metastatic GC patients treated with first-line chemotherapy. Upon validation of these data in independent studies, stratification of patients using these markers in future clinical trials is recommended.

Keywords

References

  1. Aliustaoglu M, Bilici A, Ustaalioglu BB, et al (2010). The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol, 27, 1060-5. https://doi.org/10.1007/s12032-009-9335-4
  2. Al-Shaiba R, McMillan DC, Angerson WJ, et al (2004). The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer, 91, 205-7.
  3. Asher V, Lee J, Innamaa A, et al (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503. https://doi.org/10.1007/s12094-011-0687-9
  4. Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23. https://doi.org/10.1007/s00262-008-0516-3
  5. Chua W, Charles KA, Baracos VE, et al (2011). Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 104, 1288-95. https://doi.org/10.1038/bjc.2011.100
  6. Colotta F, Allavena P, Sica A, et al (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 30, 1073-81. https://doi.org/10.1093/carcin/bgp127
  7. Crumley AB, McMillan DC, McKernan M, et al (2006). Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer, 94, 637-41.
  8. Crumley AB, Stuart RC, McKernan M, et al (2010). Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg, 34, 2393-8. https://doi.org/10.1007/s00268-010-0641-y
  9. Dalpiaz O, Ehrlich GC, Mannweiler S, et al (2013). Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. Bju Int??.
  10. Fondevila C, Metges JP, Fuster J, et al (2004). p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer, 90, 206-15. https://doi.org/10.1038/sj.bjc.6601455
  11. Fox P, Hudson M, Brown C, et al (2013). Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer, 109, 147-53. https://doi.org/10.1038/bjc.2013.300
  12. Glimelius B, Ekstrom K, Hoffman K, et al (1997). Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol, 8, 163-8. https://doi.org/10.1023/A:1008243606668
  13. Hanahan D , Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74. https://doi.org/10.1016/j.cell.2011.02.013
  14. He W, Yin C, Guo G, et al (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol, 30, 439. https://doi.org/10.1007/s12032-012-0439-x
  15. Herszenyi L , Tulassay Z (2010). Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci, 14, 249-58.
  16. Hwang JE, Kim HN, Kim DE, et al (2011). Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. Bmc Cancer, 11, 489. https://doi.org/10.1186/1471-2407-11-489
  17. Jeong JH, Lim SM, Yun JY, et al (2012). Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology, 83, 292-9. https://doi.org/10.1159/000342376
  18. Jiang X, Hiki N, Nunobe S, et al (2012). Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer, 107, 275-9. https://doi.org/10.1038/bjc.2012.262
  19. Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol, 104, 504-10. https://doi.org/10.1002/jso.21986
  20. Kanda M, Fujii T, Kodera Y, et al (2011). Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg, 98, 268-74. https://doi.org/10.1002/bjs.7305
  21. Kao SC, Pavlakis N, Harvie R, et al (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res, 16, 5805-13. https://doi.org/10.1158/1078-0432.CCR-10-2245
  22. Kasymjanova G, MacDonald N, Agulnik JS, et al (2010). The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol, 17, 52-8.
  23. Kishi Y, Kopetz S, Chun YS, et al (2009). Blood neutrophil-tolymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol, 16, 614-22. https://doi.org/10.1245/s10434-008-0267-6
  24. Kusumanto YH, Dam WA, Hospers GA, et al (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis, 6, 283-7. https://doi.org/10.1023/B:AGEN.0000029415.62384.ba
  25. Kwon HC, Kim SH, Oh SY, et al (2012). Clinical significance of preoperative neutrophil-lymphocyte versus plateletlymphocyte ratio in patients with operable colorectal cancer. Biomarkers, 17, 216-22. https://doi.org/10.3109/1354750X.2012.656705
  26. Lee S, Oh SY, Kim SH, et al (2013). Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. Bmc Cancer, 13, 350. https://doi.org/10.1186/1471-2407-13-350
  27. Leitch EF, Chakrabarti M, Crozier JE, et al (2007). Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer, 97, 1266-70. https://doi.org/10.1038/sj.bjc.6604027
  28. Lord BI, Bronchud MH, Owens S, et al (1989). The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A, 86, 9499-503. https://doi.org/10.1073/pnas.86.23.9499
  29. Maconi G, Manes G , Porro GB (2008). Role of symptoms in diagnosis and outcome of gastric cancer. World J Gastroenterol, 14, 1149-55. https://doi.org/10.3748/wjg.14.1149
  30. Mahmoud FA , Rivera NI (2002). The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep, 4, 250-5. https://doi.org/10.1007/s11912-002-0023-1
  31. Mantovani A, Allavena P, Sica A, et al (2008). Cancer-related inflammation. Nature, 454, 436-44. https://doi.org/10.1038/nature07205
  32. McMillan DC (2013). The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev, 39, 534-40. https://doi.org/10.1016/j.ctrv.2012.08.003
  33. Murad AM, Santiago FF, Petroianu A, et al (1993). Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer, 72, 37-41. https://doi.org/10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P
  34. Nozoe T, Ninomiya M, Maeda T, et al (2010). Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today, 40, 440-3. https://doi.org/10.1007/s00595-009-4065-y
  35. Oba K, Paoletti X, Bang YJ, et al (2013). Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patientdata meta-analysis. Eur J Cancer, 49, 1565-77. https://doi.org/10.1016/j.ejca.2012.12.016
  36. Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, et al (2007). Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol, 14, 381-9. https://doi.org/10.1245/s10434-006-9093-x
  37. Proctor MJ, Morrison DS, Talwar D, et al (2011). A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer, 47, 2633-41. https://doi.org/10.1016/j.ejca.2011.03.028
  38. Pyrhonen S, Kuitunen T, Nyandoto P, et al (1995). Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer, 71, 587-91. https://doi.org/10.1038/bjc.1995.114
  39. Rothwell PM, Fowkes FG, Belch JF, et al (2011). Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet, 377, 31-41. https://doi.org/10.1016/S0140-6736(10)62110-1
  40. Sarraf KM, Belcher E, Raevsky E, et al (2009). Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg, 137, 425-8. https://doi.org/10.1016/j.jtcvs.2008.05.046
  41. Sugiura T, Uesaka K, Kanemoto H, et al (2013). Elevated Preoperative Neutrophil-to-lymphocyte Ratio as a Predictor of Survival After Gastroenterostomy in Patients with Advanced Pancreatic Adenocarcinoma. Ann Surg Oncol, 20, 4330-7. https://doi.org/10.1245/s10434-013-3227-8
  42. Szkandera J, Gerger A, Liegl-Atzwanger B, et al (2013). Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients. Br J Cancer, 109, 2316-22. https://doi.org/10.1038/bjc.2013.595
  43. Ulich TR, Del CJ, Keys M, et al (1987). Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol, 139, 3406-15.
  44. Xia WX, Ye YF, Lu X, et al (2013). The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy. PLoS One, 8, e76958. https://doi.org/10.1371/journal.pone.0076958
  45. Yamanaka T, Matsumoto S, Teramukai S, et al (2007). The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology, 73, 215-20 https://doi.org/10.1159/000127412

Cited by

  1. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis vol.140, pp.9, 2014, https://doi.org/10.1007/s00432-014-1714-3
  2. Prognostic Value of Preoperative Inflammation-Based Prognostic Scores on Hospital Mortality after Gastric Cancer Surgery vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7909
  3. Relationship Between Prognosis and Neutrophil: Lymphocyte and Platelet:Lymphocyte Ratios in Patients with Malignant Pleural Mesotheliomas vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2061
  4. Genotype CC of rs1800947 in the C-Reactive Protein Gene May Increase Susceptibility to Colorectal Cancer: a Meta-Analysis vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2663
  5. Significance of Preoperative Total Lymphocyte Count as a Prognostic Criterion in Adult Cardiac Surgery vol.4, pp.3, 2014, https://doi.org/10.5812/aapm.20331
  6. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0530-9
  7. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5933
  8. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3997
  9. The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China vol.94, pp.1, 2015, https://doi.org/10.1007/s00277-014-2167-0
  10. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT vol.11, pp.7, 2016, https://doi.org/10.1371/journal.pone.0159506
  11. Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer vol.128, pp.17-18, 2016, https://doi.org/10.1007/s00508-015-0724-8
  12. Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer vol.14, pp.1, 2016, https://doi.org/10.1186/s12957-016-0904-7
  13. Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2066-y
  14. Clinical severity in forecasting platelet to lymphocyte ratio in Crimean–Congo hemorrhagic fever patients vol.65, pp.10, 2016, https://doi.org/10.1099/jmm.0.000330
  15. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma vol.39, pp.4, 2017, https://doi.org/10.1002/hed.24658
  16. Platelet Distribution Width as a Predictor of Metastasis in Gastric Cancer Patients vol.48, pp.4, 2017, https://doi.org/10.1007/s12029-016-9886-5
  17. The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer vol.66, pp.6, 2017, https://doi.org/10.1007/s00011-017-1026-6
  18. Associations Between Nutritional Parameters and Clinicopathologic Factors in Patients with Gastric Cancer: A Comprehensive Study vol.69, pp.5, 2017, https://doi.org/10.1080/01635581.2017.1324993
  19. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma vol.94, pp.49, 2015, https://doi.org/10.1097/MD.0000000000002133
  20. Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer vol.95, pp.40, 2016, https://doi.org/10.1097/MD.0000000000005024
  21. Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy vol.14, pp.24, 2018, https://doi.org/10.2217/fon-2018-0167
  22. The neutrophil-to-lymphocyte ratio prechemotherapy and postchemotherapy as a prognostic marker in metastatic gastric cancer vol.33, pp.5, 2018, https://doi.org/10.3904/kjim.2016.293
  23. The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers vol.18, pp.1, 2018, https://doi.org/10.1186/s12876-018-0812-0